Category: CNS/Neurology
CNS/Neurology market research reports by DelveInsight
-
Restless Leg Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034
Restless Leg Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Restless Leg Syndrome – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Restless Leg Syndrome, historical and forecasted epidemiology as well ... Read More
-
Brain Hemorrhage – Market Insight, Epidemiology, and Market Forecast – 2034
Brain Hemorrhage – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Brain Hemorrhage – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Brain Hemorrhage, historical and forecasted epidemiology as well as the Brain H ... Read More
-
Meniere's Disease – Market Insight, Epidemiology, and Market Forecast – 2034
Meniere's Disease – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Meniere's Disease – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Meniere's Disease, historical and forecasted epidemiology as well as the Meni ... Read More
-
Concussions – Market Insight, Epidemiology, and Market Forecast – 2034
Concussions – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Concussions – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Concussions, historical and forecasted epidemiology as well as the Concussions market tre ... Read More
-
Vertigo – Market Insight, Epidemiology, and Market Forecast – 2034
Vertigo – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Vertigo – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Vertigo, historical and forecasted epidemiology as well as the Vertigo market trends in the Unite ... Read More
-
Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024
Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024 DelveInsight’s, “Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Post-traumatic Stress Disorder (PTSD) pipeline landscape. It covers th ... Read More
-
Anorexia Nervosa - Pipeline Insight, 2024
Anorexia Nervosa - Pipeline Insight, 2024 DelveInsight’s, “Anorexia Nervosa - Pipeline Insight, 2024” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Anorexia Nervosa pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stag ... Read More
-
Equine encephalitis - Pipeline Insight, 2024
Equine encephalitis - Pipeline Insight, 2024 DelveInsight’s, “Equine encephalitis - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Equine encephalitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclin ... Read More
-
Cognitive Impairment Associated with Schizophrenia-CIAS-Pipeline Insight, 2024
Cognitive Impairment Associated with Schizophrenia-CIAS-Pipeline Insight, 2024 DelveInsight’s, “Cognitive Impairment Associated with Schizophrenia-CIAS- Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cognitive Impairment Associated with Sc ... Read More
-
Glioblastoma- Pipeline Insight, 2024
Glioblastoma- Pipeline Insight, 2024 DelveInsight’s, “Glioblastoma- Pipeline Insight, 2024” report provides comprehensive insights about 195+ companies and 210+ pipeline drugs in Glioblastoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More
-
5-HT1 Antagonist - Pipeline Insight, 2024
5-HT1 Antagonist - Pipeline Insight, 2024 “5-HT1 Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1 Antagonist development. The report provides detailed coverage of the ... Read More
-
Obese patients with Schizophrenia - Pipeline Insight, 2024
Obese patients with Schizophrenia - Pipeline Insight, 2024 Obese patients with Schizophrenia Overview ""Obese patients with Schizophrenia Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Obese pati ... Read More
-
Acute Social Anxiety Disorder - Pipeline Insight, 2024
Acute Social Anxiety Disorder - Pipeline Insight, 2024 Acute Social Anxiety Disorder Overview ""Acute Social Anxiety Disorder Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Social Anxiety D ... Read More
-
Glioma - Pipeline Insight, 2024
Glioma - Pipeline Insight, 2024 DelveInsight’s, “Glioma - Pipeline Insight, 2024” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Glioma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More
-
Traumatic Brain Injury(TBI) - Pipeline Insight, 2024
Traumatic Brain Injury(TBI) - Pipeline Insight, 2024 Traumatic Brain Injury(TBI) Overview ""Traumatic Brain Injury(TBI) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Traumatic Brain Injury(TBI) ... Read More
-
Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2024
Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2024 Therapy Resistant Psychiatric Disorders Overview ""Therapy Resistant Psychiatric Disorders Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects acr ... Read More
-
Schizophrenia - Epidemiology Forecast - 2034
Schizophrenia - Epidemiology Forecast - 2034 DelveInsight’s ‘Schizophrenia – Epidemiology Forecast – 2034’ report delivers an in-depth understanding of schizophrenia, historical and forecasted epidemiology, as well as the trends in the United States, EU4 (Germany, France, Italy, and Spain), and the ... Read More
-
Schizophrenia Market Insight, Epidemiology And Market Forecast - 2034
Schizophrenia Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The prevalence of cervical dystonia is projected to increase during the forecast period (2023–2034). This increase is attributed to heightened awareness among healthcare professionals and the general public regardin ... Read More
-
Down Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
Down Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the total market size of Peripheral Nerve Injuries accounted for ~USD 2.4 billion in the 7MM. In 2023, annual number of peripheral number injuries of upper extremities in the 7MM were ~2.9 million and of ... Read More
-
Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology And Market Forecast - 2034
Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Malignant ascites (MA) is a pathological condition due to a variety of primary abdominal and extra-abdominal neoplasms. It is a primary cause of morbidity and presents many difficulties and t ... Read More
-
Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024
Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024 DelveInsight’s, “Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Post-traumatic Stress Disorder (PTSD) pipeline landscape. It covers th ... Read More
-
Anorexia Nervosa - Pipeline Insight, 2024
Anorexia Nervosa - Pipeline Insight, 2024 DelveInsight’s, “Anorexia Nervosa - Pipeline Insight, 2024” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Anorexia Nervosa pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stag ... Read More
-
Anti-Depressant Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
Anti-Depressant Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Anti-Depressant Drugs Market By Drug Type (Selective Serotonin Reuptake Inhibitors (SSRI), Selective-Norepinephrine Reuptake Inhibitors (SNRI), Tricyclic Antidepressants (TCA), Monoamine Oxidase Inhibit ... Read More
-
Traumatic Brain Injury - Market Insight, Epidemiology And Market Forecast - 2034
Traumatic Brain Injury - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Idiopathic Membranous Nephropathy (IMN) is a significant type of glomerular disease characterized by the presence of large amounts of protein in the urine (nephrotic syndrome) and is primarily an autoimmu ... Read More
-
Schizophrenia- Pipeline Insight, 2024
Schizophrenia- Pipeline Insight, 2024 DelveInsight’s, “Schizophrenia- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Schizophrenia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More
Research Assistance
